Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.95, $0.13 better than the analyst estimate of $0.82. Revenue for the quarter came in at $1.25 billion versus the consensus estimate of $1.24 billion.

GUIDANCE:

Encompass Health Corporation sees FY2024 EPS of $3.77-$4.06, versus the consensus of $3.84. Encompass Health Corporation sees FY2024 revenue of $5.2-5.3 billion, versus the consensus of $5.194 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.